Table of Content

1 Market Overview of Gene-based Therapy Medicinal
1.1 Gene-based Therapy Medicinal Market Overview
1.1.1 Gene-based Therapy Medicinal Product Scope
1.1.2 Gene-based Therapy Medicinal Market Status and Outlook
1.2 Global Gene-based Therapy Medicinal Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Gene-based Therapy Medicinal Market Size by Region (2018-2029)
1.4 Global Gene-based Therapy Medicinal Historic Market Size by Region (2018-2024)
1.5 Global Gene-based Therapy Medicinal Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Gene-based Therapy Medicinal Market Size (2018-2029)
1.6.1 North America Gene-based Therapy Medicinal Market Size (2018-2029)
1.6.2 Europe Gene-based Therapy Medicinal Market Size (2018-2029)
1.6.3 Asia-Pacific Gene-based Therapy Medicinal Market Size (2018-2029)
1.6.4 Latin America Gene-based Therapy Medicinal Market Size (2018-2029)
1.6.5 Middle East & Africa Gene-based Therapy Medicinal Market Size (2018-2029)
2 Gene-based Therapy Medicinal Market by Type
2.1 Introduction
2.1.1 Viral Gene Delivery System
2.1.2 Non-viral Gene Delivery System
2.2 Global Gene-based Therapy Medicinal Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Gene-based Therapy Medicinal Historic Market Size by Type (2018-2024)
2.2.2 Global Gene-based Therapy Medicinal Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Gene-based Therapy Medicinal Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Gene-based Therapy Medicinal Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Gene-based Therapy Medicinal Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Gene-based Therapy Medicinal Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Gene-based Therapy Medicinal Revenue Breakdown by Type (2018-2029)
3 Gene-based Therapy Medicinal Market Overview by Application
3.1 Introduction
3.1.1 Neurological Diseases
3.1.2 Cancer
3.1.3 Other
3.2 Global Gene-based Therapy Medicinal Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Gene-based Therapy Medicinal Historic Market Size by Application (2018-2024)
3.2.2 Global Gene-based Therapy Medicinal Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Gene-based Therapy Medicinal Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Gene-based Therapy Medicinal Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Gene-based Therapy Medicinal Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Gene-based Therapy Medicinal Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Gene-based Therapy Medicinal Revenue Breakdown by Application (2018-2029)
4 Gene-based Therapy Medicinal Competition Analysis by Players
4.1 Global Gene-based Therapy Medicinal Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene-based Therapy Medicinal as of 2022)
4.3 Date of Key Players Enter into Gene-based Therapy Medicinal Market
4.4 Global Top Players Gene-based Therapy Medicinal Headquarters and Area Served
4.5 Key Players Gene-based Therapy Medicinal Product Solution and Service
4.6 Competitive Status
4.6.1 Gene-based Therapy Medicinal Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biogen
5.1.1 Biogen Profile
5.1.2 Biogen Main Business
5.1.3 Biogen Gene-based Therapy Medicinal Products, Services and Solutions
5.1.4 Biogen Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.1.5 Biogen Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Gene-based Therapy Medicinal Products, Services and Solutions
5.2.4 Novartis Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.2.5 Novartis Recent Developments
5.3 Gilead Sciences
5.3.1 Gilead Sciences Profile
5.3.2 Gilead Sciences Main Business
5.3.3 Gilead Sciences Gene-based Therapy Medicinal Products, Services and Solutions
5.3.4 Gilead Sciences Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.3.5 Sarepta Therapeutics Recent Developments
5.4 Sarepta Therapeutics
5.4.1 Sarepta Therapeutics Profile
5.4.2 Sarepta Therapeutics Main Business
5.4.3 Sarepta Therapeutics Gene-based Therapy Medicinal Products, Services and Solutions
5.4.4 Sarepta Therapeutics Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.4.5 Sarepta Therapeutics Recent Developments
5.5 Alnylam Pharmaceuticals
5.5.1 Alnylam Pharmaceuticals Profile
5.5.2 Alnylam Pharmaceuticals Main Business
5.5.3 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Products, Services and Solutions
5.5.4 Alnylam Pharmaceuticals Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.5.5 Alnylam Pharmaceuticals Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Gene-based Therapy Medicinal Products, Services and Solutions
5.6.4 Amgen Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.6.5 Amgen Recent Developments
5.7 Spark Therapeutics
5.7.1 Spark Therapeutics Profile
5.7.2 Spark Therapeutics Main Business
5.7.3 Spark Therapeutics Gene-based Therapy Medicinal Products, Services and Solutions
5.7.4 Spark Therapeutics Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.7.5 Spark Therapeutics Recent Developments
5.8 Akcea Therapeutics
5.8.1 Akcea Therapeutics Profile
5.8.2 Akcea Therapeutics Main Business
5.8.3 Akcea Therapeutics Gene-based Therapy Medicinal Products, Services and Solutions
5.8.4 Akcea Therapeutics Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.8.5 Akcea Therapeutics Recent Developments
5.9 Sunway Biotech
5.9.1 Sunway Biotech Profile
5.9.2 Sunway Biotech Main Business
5.9.3 Sunway Biotech Gene-based Therapy Medicinal Products, Services and Solutions
5.9.4 Sunway Biotech Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.9.5 Sunway Biotech Recent Developments
5.10 SIBIONO
5.10.1 SIBIONO Profile
5.10.2 SIBIONO Main Business
5.10.3 SIBIONO Gene-based Therapy Medicinal Products, Services and Solutions
5.10.4 SIBIONO Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.10.5 SIBIONO Recent Developments
5.11 AnGes
5.11.1 AnGes Profile
5.11.2 AnGes Main Business
5.11.3 AnGes Gene-based Therapy Medicinal Products, Services and Solutions
5.11.4 AnGes Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.11.5 AnGes Recent Developments
5.12 Orchard Therapeutics
5.12.1 Orchard Therapeutics Profile
5.12.2 Orchard Therapeutics Main Business
5.12.3 Orchard Therapeutics Gene-based Therapy Medicinal Products, Services and Solutions
5.12.4 Orchard Therapeutics Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.12.5 Orchard Therapeutics Recent Developments
5.13 Human Stem Cells Institute
5.13.1 Human Stem Cells Institute Profile
5.13.2 Human Stem Cells Institute Main Business
5.13.3 Human Stem Cells Institute Gene-based Therapy Medicinal Products, Services and Solutions
5.13.4 Human Stem Cells Institute Gene-based Therapy Medicinal Revenue (US$ Million) & (2018-2024)
5.13.5 Human Stem Cells Institute Recent Developments
6 North America
6.1 North America Gene-based Therapy Medicinal Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Gene-based Therapy Medicinal Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Gene-based Therapy Medicinal Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Gene-based Therapy Medicinal Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Gene-based Therapy Medicinal Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Gene-based Therapy Medicinal Market Dynamics
11.1 Gene-based Therapy Medicinal Industry Trends
11.2 Gene-based Therapy Medicinal Market Drivers
11.3 Gene-based Therapy Medicinal Market Challenges
11.4 Gene-based Therapy Medicinal Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Gene-based Therapy Medicinal Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Gene-based Therapy Medicinal Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Gene-based Therapy Medicinal Market Size Share by Region (2018-2024)
Table 4. Global Gene-based Therapy Medicinal Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Gene-based Therapy Medicinal Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Gene-based Therapy Medicinal Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Gene-based Therapy Medicinal Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Gene-based Therapy Medicinal Revenue Market Share by Type (2018-2024)
Table 9. Global Gene-based Therapy Medicinal Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Gene-based Therapy Medicinal Revenue Market Share by Type (2024-2029)
Table 11. North America Gene-based Therapy Medicinal Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Gene-based Therapy Medicinal Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Gene-based Therapy Medicinal Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Gene-based Therapy Medicinal Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Gene-based Therapy Medicinal Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Gene-based Therapy Medicinal Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Gene-based Therapy Medicinal Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Gene-based Therapy Medicinal Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Gene-based Therapy Medicinal Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Gene-based Therapy Medicinal Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Gene-based Therapy Medicinal Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Gene-based Therapy Medicinal Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Gene-based Therapy Medicinal Revenue Market Share by Application (2018-2024)
Table 24. Global Gene-based Therapy Medicinal Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Gene-based Therapy Medicinal Revenue Market Share by Application (2024-2029)
Table 26. North America Gene-based Therapy Medicinal Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Gene-based Therapy Medicinal Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Gene-based Therapy Medicinal Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Gene-based Therapy Medicinal Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Gene-based Therapy Medicinal Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Gene-based Therapy Medicinal Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Gene-based Therapy Medicinal Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Gene-based Therapy Medicinal Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Gene-based Therapy Medicinal Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Gene-based Therapy Medicinal Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Gene-based Therapy Medicinal Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Gene-based Therapy Medicinal Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene-based Therapy Medicinal as of 2022)
Table 39. Date of Key Players Enter into Gene-based Therapy Medicinal Market
Table 40. Global Gene-based Therapy Medicinal Key Players Headquarters and Area Served
Table 41. Gene-based Therapy Medicinal Product Solution and Service
Table 42. Global Gene-based Therapy Medicinal Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Biogen Basic Information List
Table 45. Biogen Description and Business Overview
Table 46. Biogen Gene-based Therapy Medicinal Products, Services and Solutions
Table 47. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Biogen (2018-2024)
Table 48. Biogen Recent Developments
Table 49. Novartis Basic Information List
Table 50. Novartis Description and Business Overview
Table 51. Novartis Gene-based Therapy Medicinal Products, Services and Solutions
Table 52. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Novartis (2018-2024)
Table 53. Novartis Recent Developments
Table 54. Gilead Sciences Basic Information List
Table 55. Gilead Sciences Description and Business Overview
Table 56. Gilead Sciences Gene-based Therapy Medicinal Products, Services and Solutions
Table 57. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Gilead Sciences (2018-2024)
Table 58. Gilead Sciences Recent Developments
Table 59. Sarepta Therapeutics Basic Information List
Table 60. Sarepta Therapeutics Description and Business Overview
Table 61. Sarepta Therapeutics Gene-based Therapy Medicinal Products, Services and Solutions
Table 62. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Sarepta Therapeutics (2018-2024)
Table 63. Sarepta Therapeutics Recent Developments
Table 64. Alnylam Pharmaceuticals Basic Information List
Table 65. Alnylam Pharmaceuticals Description and Business Overview
Table 66. Alnylam Pharmaceuticals Gene-based Therapy Medicinal Products, Services and Solutions
Table 67. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Alnylam Pharmaceuticals (2018-2024)
Table 68. Alnylam Pharmaceuticals Recent Developments
Table 69. Amgen Basic Information List
Table 70. Amgen Description and Business Overview
Table 71. Amgen Gene-based Therapy Medicinal Products, Services and Solutions
Table 72. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Amgen (2018-2024)
Table 73. Amgen Recent Developments
Table 74. Spark Therapeutics Basic Information List
Table 75. Spark Therapeutics Description and Business Overview
Table 76. Spark Therapeutics Gene-based Therapy Medicinal Products, Services and Solutions
Table 77. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Spark Therapeutics (2018-2024)
Table 78. Spark Therapeutics Recent Developments
Table 79. Akcea Therapeutics Basic Information List
Table 80. Akcea Therapeutics Description and Business Overview
Table 81. Akcea Therapeutics Gene-based Therapy Medicinal Products, Services and Solutions
Table 82. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Akcea Therapeutics (2018-2024)
Table 83. Akcea Therapeutics Recent Developments
Table 84. Sunway Biotech Basic Information List
Table 85. Sunway Biotech Description and Business Overview
Table 86. Sunway Biotech Gene-based Therapy Medicinal Products, Services and Solutions
Table 87. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Sunway Biotech (2018-2024)
Table 88. Sunway Biotech Recent Developments
Table 89. SIBIONO Basic Information List
Table 90. SIBIONO Description and Business Overview
Table 91. SIBIONO Gene-based Therapy Medicinal Products, Services and Solutions
Table 92. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of SIBIONO (2018-2024)
Table 93. SIBIONO Recent Developments
Table 94. AnGes Basic Information List
Table 95. AnGes Description and Business Overview
Table 96. AnGes Gene-based Therapy Medicinal Products, Services and Solutions
Table 97. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of AnGes (2018-2024)
Table 98. AnGes Recent Developments
Table 99. Orchard Therapeutics Basic Information List
Table 100. Orchard Therapeutics Description and Business Overview
Table 101. Orchard Therapeutics Gene-based Therapy Medicinal Products, Services and Solutions
Table 102. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Orchard Therapeutics (2018-2024)
Table 103. Orchard Therapeutics Recent Developments
Table 104. Human Stem Cells Institute Basic Information List
Table 105. Human Stem Cells Institute Description and Business Overview
Table 106. Human Stem Cells Institute Gene-based Therapy Medicinal Products, Services and Solutions
Table 107. Revenue (US$ Million) in Gene-based Therapy Medicinal Business of Human Stem Cells Institute (2018-2024)
Table 108. Human Stem Cells Institute Recent Developments
Table 109. North America Gene-based Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 110. North America Gene-based Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 111. Europe Gene-based Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 112. Europe Gene-based Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 113. Asia-Pacific Gene-based Therapy Medicinal Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 114. Asia-Pacific Gene-based Therapy Medicinal Market Size by Region (2018-2024) & (US$ Million)
Table 115. Asia-Pacific Gene-based Therapy Medicinal Market Size by Region (2024-2029) & (US$ Million)
Table 116. Asia-Pacific Gene-based Therapy Medicinal Market Share by Region (2018-2024)
Table 117. Asia-Pacific Gene-based Therapy Medicinal Market Share by Region (2024-2029)
Table 118. Latin America Gene-based Therapy Medicinal Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 119. Latin America Gene-based Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 120. Latin America Gene-based Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 121. Middle East & Africa Gene-based Therapy Medicinal Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 122. Middle East & Africa Gene-based Therapy Medicinal Market Size by Country (2018-2024) & (US$ Million)
Table 123. Middle East & Africa Gene-based Therapy Medicinal Market Size by Country (2024-2029) & (US$ Million)
Table 124. Gene-based Therapy Medicinal Market Trends
Table 125. Gene-based Therapy Medicinal Market Drivers
Table 126. Gene-based Therapy Medicinal Market Challenges
Table 127. Gene-based Therapy Medicinal Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene-based Therapy Medicinal Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Gene-based Therapy Medicinal Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Gene-based Therapy Medicinal Market Share by Regions: 2022 VS 2029
Figure 4. Global Gene-based Therapy Medicinal Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Gene-based Therapy Medicinal Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Viral Gene Delivery System
Figure 11. Global Viral Gene Delivery System Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Non-viral Gene Delivery System
Figure 13. Global Non-viral Gene Delivery System Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Gene-based Therapy Medicinal Market Size Share by Type: 2022 & 2029
Figure 15. North America Gene-based Therapy Medicinal Revenue Market Share by Type (2018-2029)
Figure 16. Europe Gene-based Therapy Medicinal Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Gene-based Therapy Medicinal Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Gene-based Therapy Medicinal Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Gene-based Therapy Medicinal Revenue Market Share by Type (2018-2029)
Figure 20. Neurological Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Global Gene-based Therapy Medicinal Market Size Share by Application: 2022 & 2029
Figure 24. North America Gene-based Therapy Medicinal Revenue Market Share by Application (2018-2029)
Figure 25. Europe Gene-based Therapy Medicinal Revenue Market Share by Application (2018-2029)
Figure 26. Asia-Pacific Gene-based Therapy Medicinal Revenue Market Share by Application (2018-2029)
Figure 27. Latin America Gene-based Therapy Medicinal Revenue Market Share by Application (2018-2029)
Figure 28. Middle East and Africa Gene-based Therapy Medicinal Revenue Market Share by Application (2018-2029)
Figure 29. Gene-based Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players Gene-based Therapy Medicinal Market Share in 2022
Figure 31. North America Gene-based Therapy Medicinal Market Share by Country (2018-2029)
Figure 32. United States Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 33. Canada Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 34. Germany Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 35. France Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 36. U.K. Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 37. Italy Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 38. Russia Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 39. Nordic Countries Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 40. Asia-Pacific Gene-based Therapy Medicinal Market Share by Region (2018-2029)
Figure 41. China Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 42. Japan Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 43. South Korea Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 45. India Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 46. Australia Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 47. Latin America Gene-based Therapy Medicinal Market Share by Country (2018-2029)
Figure 48. Mexico Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 49. Brazil Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Gene-based Therapy Medicinal Market Share by Country (2018-2029)
Figure 51. Turkey Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 53. UAE Gene-based Therapy Medicinal Market Size (2018-2029) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report